Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

$PRCTPress releaseAug 10, 2026, 2:11 PM ETRead the release

Kahn Swick & Foti issued a solicitation for a securities class action lawsuit against PROCEPT BioRobotics, reminding investors of a September 22, 2026 deadline to file lead plaintiff applications. The complaint alleges that the company failed to disclose excess field inventory of over 10,000 units, which contributed to a reported 30% sequential decline in handpiece sales and an 18% stock drop in February 2026.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.